ALMIRALL, S.A. desde 28/09/2016 hasta 28/09/2016 28/09/2016 18:37 ALMIRALL, S.A. Others on business performance and financial information Almirall announces positive phase III results showing efficacy of LAS41008 (dimethyl fumarate), a new systemic oral drug for patients with chronic plaque psoriasis Número de registro: 243184 28/09/2016 18:30 ALMIRALL, S.A. Others on business performance and financial information Almirall presenta resultados positivos de fase III que demuestran la eficacia de LAS41008 (dimetil fumarato), un nuevo fármaco oral sistémico para pacientes con psoriasis en placa Número de registro: 243183